Skip to main content
Premium Trial:

Request an Annual Quote

Curidium Joins Personalized Medicine Coalition

NEW YORK (GenomeWeb News) - Curidium Medica said today that it has joined the Personalized Medicine Coalition, a US-based non-profit that aims to advance personalized medicine concepts and products.
 
The PMC is composed of pharmaceutical, biotechnology, diagnostics, and information technology companies.
 
Curidium is a UK-based developer of blood-based diagnostics for disorders of the central nervous system.
 
Earlier this week, the company said it had raised around $5 million in a share offering to fund development of PsychINDx test, a blood-based diagnostic that categorizes patients with schizophrenia/bipolar disorder into four subgroups.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.